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Abstract 
The purpose of this study was to gain insight in what Rx legend drugs pharmacists think have a good enough safety profile to sell as 
OTC and, if any, what OTC drugs pharmacists think should be legend only.  This study was performed as a non-directional survey 
asking the 2 following questions: “What are some prescription only medications that you think would be okay to sell as 
nonprescription (over-the-counter and behind the counter)” and following that “If any, what are some OTC/BTC medications that you 
think should be prescription only?”  Pharmacists who were surveyed were those in the Philadelphia area within convenient traveling 
distance or whose contact information was available or accessible.  There were three modes of collecting data.  The first method was 
traveling to pharmacies in person and giving the pharmacist a physical survey to complete.  The second method was the creation of a 
survey monkey, identical to the physical survey, which was sent electronically via email, text, or Facebook.  The third method was 
telephoning pharmacies and conducting the survey over the phone.  Demographics of respondents’ age range, education, area of 
work, and gender were collected.  All methods were done as similarly as possible; with the same greeting and wording of questions, 
etc.  Data analysis was done based on noticeable trends of answers and tallying frequencies of responses. In all, 101 pharmacists 
were contacted.  The most common suggestion for Rx-to-OTC switch was oral contraceptives. 
 
 
Introduction 
In 1951, the Durham-Humphrey Amendment was passed, 
requiring that any habit forming or potentially harmful drug 
must be dispensed under direct medical supervision by a 
healthcare practitioner.  The amendment differentiated 
between legend (Rx) drugs and OTC drugs.  Prescription drugs 
must carry the statement “Caution: Federal law prohibits 
dispensing without prescription.”  All other drugs have OTC 
status.  Until this time, there was a lack of statutory direction 
and the responsibility of who designated what was a 
prescription or non-prescription, the FDA, regulated industry, 
or professional pharmacy, was undetermined.1   
 
In 1962, the Kefauver-Harris Amendments were passed, 
establishing a formal process that required drug 
manufacturers to clinically prove not only safety, but efficacy 
of medications and to report serious adverse events.  This bill 
was likely in response to the crisis in 1962 of thalidomide, a 
morning sickness medication for pregnant women, which 
caused devastating birth defects in Europe.  There were some 
limitations to the FDA.  For example, the FDA couldn’t 
prevent manufacturers from selling a drug if the FDA didn’t 
act within 60 days of the drug’s marketing.  The FDA also  
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couldn’t enforce good manufacturing processes and accurate 
prescription drug advertising before this act.  More 
importantly, this act required FDA approval before a drug can 
be marketed in the US.1,2   
 
With the Kefauver-Harris expansion of FDA authority, the 
Drug Efficacy Study Implementation (DESI) project was 
launched to evaluate the efficacy of drug products, including 
OTC, which reached the drug market from 1938 to 1962 that 
were initially based entirely on safety, prior to the 1962 FDA 
regulation amendments.1,3 
 
In 1972, the FDA launched the OTC Drug Review to review the 
safety and efficacy of the ingredients, doses, formulations, 
and labeling used in medications available without 
prescription.3 
 
Rx-to-OTC switch is when a drug with prescription status (Rx) 
transfers to nonprescription over-the-counter (OTC) status 
for either the same or a related indication.  Rx-to-OTC switch 
is a highly regulated process that allows consumers to have 
easier access to medications without having to go to the 
doctor.  Some examples include nicotine replacement 
therapies (gum, patch, and lozenge), ibuprofen 200mg, 
Benadryl (diphenhydramine), Claritin (loratidine), Nexium 
(esomeprazole), and Flonase (fluticasone). 
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Some of the requirements for a drug to switch are that the 
drug must have a wide safety margin, efficacy, and easy to 
understand labeling and language to ensure proper use.  
Consumers must also be able to self-recognize and self-
medicate a condition, and to understand warnings.4 
 
There is definitely some conversation about the utility of the 
Rx-to-OTC switch.  On the one hand, increasing access to 
frequently used medications with benign side effects that 
require prescriptions can lead to cost savings.  The downside 
is that, even with benign side effects, many medications still 
require counseling or monitoring of some sort to maintain 
safety.  In addition, patients need to be able to effectively 
self-diagnose to be successful in OTC therapy.  One such 
study attempting to show the economic benefits was done 
estimating the potential switch of a triptan from Rx to OTC in 
France, UK, Spain, Italy, Germany, and Poland.  This study 
took into account factors including time away from work, 
pathology, populations that tend to get migraines, and so 
on.  What they found is that the overall spending for migraine 
attacks across the 6 countries came to $661 million annually 
with potential savings of 13% if only one triptan were to go 
OTC.  The model in this study may not necessarily correlate in 
the US because of different healthcare spending methods 
(single-payer vs. multi-payer).5 
 
In a study of OTC Nicotine-Replacement-Therapy (NRT), it was 
found that the OTC availability of NRT increased access to and 
utilization of treatment with safe and efficacious use, and 
without substantial misuse or abuse.  Prior to the switch, NRT 
was not widely used despite proven efficacy in smoking 
cessation.  This study helped show that the Rx-to-OTC switch 
can increase utilization.  This study may suggest potential for 
other switches to address public health needs.6 
 
OTC medication sales make up 8% of total US pharma sales 
volume.  The availability of OTC medications has great value 
in the US healthcare system in the form of $102 billion in 
annual healthcare savings because of unneeded physician 
visits and diagnostic tests avoided.  Currently, the OTC sector 
is about $40 billion in size.  Rx-to-OTC switch category drugs 
accounted for 19% of OTC sales in the past 5 years.7 
 
Study Methodology 
The purpose of the study described here was a pilot study to 
gain insight in what Rx legend drugs pharmacists think have a 
good enough safety profile to sell as OTC and, if any, what 
OTC drugs pharmacists think should be legend only.   
 
Method:  This study was performed as a non-directional 
survey asking the 2 following questions: “What are some 
prescription only medications that you think would be okay 
to sell as nonprescription (over-the-counter and behind the 
counter)” and following that “If any, what are some OTC/BTC 
medications that you think should be prescription only?”  
Examples of drugs that went through the Rx-to-OTC switch 
were given including Plan B, Mucinex, Benadryl, 
Hydrocortisone 1% cream, and Allegra.   
 
The survey was conducted from September 1, 2015 to 
November 30, 2015.  Pharmacists who were surveyed were 
those in the Philadelphia area within convenient traveling 
distance or whose contact information was available or 
accessible.  There were three modes of collecting data.  The 
first method was traveling to pharmacies in person and giving 
the pharmacist a physical survey to complete.  The second 
method was the creation of a survey monkey, identical to the 
physical survey, which was sent electronically via email, text, 
or Facebook.  The third method was telephoning pharmacies 
and conducting the survey over the phone.  Demographics of 
respondents’ age range, education, area of work, and gender 
were collected.  All methods were done as similarly as 
possible; with the same greeting and wording of questions, 
etc.  Data analysis was done based on noticeable trends of 
answers and tallying frequencies of responses.  
 
In all, 101 pharmacists were contacted; 21 in person, 45 by 
telephone, and 35 by electronic means.  A sample of the 
survey instrument is found in appendix A. 
 
This convenience sample is not intended to be generalizable, 
but rather is a pilot study to determine whether a larger, 
more diverse study might yield interesting and actionable 
results.   
 
Findings 
The demographics of the 101 surveyed are found in Table 1.  
The results for the #1 question “What are some prescription 
only medications that you think would be okay to sell as 
nonprescription (over-the-counter and behind the counter)” 
are found in Table 2.   The results for the #2 question “If any, 
what are some OTC/BTC medications that you think should 
be prescription only?” are found in Table 3. 
 
Discussion 
This discussion will focus mainly on the most frequent 
responses.  By count, the most common response for Rx-to-
OTC switch received was all oral contraceptives, where 40 out 
of 101 pharmacists responded.  Of the 40 pharmacists, 26 
were male and 14 were female.  This finding may be 
potentiated due to the fact that oral contraceptives are a 
medication that females take, so males may not quite see the 
harm.  It is also a possibility that since a majority of the 
respondents were from a retail setting, these suggestions 
were to ease the burden of refills and calls.  However, 31 of 
the pharmacists had a Pharm.D. and 9 had a B.S.  Pharmacists 
with a Pharm.D. degree have more extensive clinical 
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knowledge of disease states and medications, which may lend 
support in the safety profile of oral contraceptives to switch 
them to OTC since the majority of respondents held a 
Pharm.D.  Although there was no distinction between over-
the-counter and behind-the-counter, oral contraceptives 
would likely be sold behind-the-counter because there are 
major counseling points associated with them, including but 
not limited to selecting the dosage of either the estrogen or 
progesterone component, medication adherence, and what 
to do with missed dosages. 
 
The three most frequent medications following oral 
contraceptives are life-saving medications albuterol, epi-pen, 
and naloxone.  One reason for these suggestions may be that 
albuterol and Epi-pen medications may frequently run out of 
refills or the prescriptions expire when they are needed 
because these medications aren’t used consistently.  
Naloxone is an interesting suggestion; retail chains in PA are 
starting to obtain standing orders from physicians so that the 
pharmacist can prescribe naloxone.  Nasonex nasal spray was 
the fifth most frequent, likely because Flonase is also OTC and 
they are similar.   
 
The most frequent suggestion of OTC medications that should 
be moved to Rx was Plan B, with 10 out of 45 pharmacists 
that responded to this question.  This is an interesting result 
because the most frequent suggestion for Rx-to-OTC switch 
was oral contraceptives.  Of the 10 responses, 6 were males 
and 4 were females.  8 of the respondents had Pharm.D and 2 
had B.S.  6 of the respondents included birth control as a 
suggestion, 5 of them being male and 1 female.   
 
Although the suggestion of all herbals was second in 
frequency, this does not take into account specific herbal 
suggestions such as black cohosh, gingko biloba, ginseng, red 
yeast rice, and other herbals that may be thought of as 
supplements like weight loss supplements.  This suggestion is 
likely due to the fact that there is little evidence of the 
efficacy of many herbal supplements.  Many herbal 
supplements have known interactions with medications.   
There may also be many more unknown interactions with 
herbals alone or in combination with medications than the 
interactions known.  Herbal supplements are less regulated 
than FDA approved medications and can pose a threat to 
patient safety.    
 
Conclusion 
There are many prescription medications that practicing 
pharmacists believe are safe to sell as OTC.  The most 
common medication is of oral contraceptives.  This finding is 
potentiated by the fact that California and Oregon have 
recently passed laws allowing pharmacists to prescribe both 
oral and hormonal contraceptives, being implemented in 
2016.8  These two states serve as examples of the services 
that pharmacists can provide.  If there is success with 
California and Nevada in the advancement of women’s health 
by allowing pharmacists to prescribe contraceptives, we can 
expect that other states will follow suit.   It is not 
unreasonable to expect that contraceptives have potential to 
be sold as non-prescription in the future.   
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Table 1: Demographics of Pharmacists Surveyed 
 
Demographic Frequency 
Gender   
Male 57 
Female 44 
Education   
Pharm.D 71 
BS 30 
Age Range   
20s 35 
30s 33 
40s 7 
50s 23 
60s 2 
70s 1 
Employment Status 
 Retail* 72 
Hospital 14 
Academia 8 
Home infusion 5 
Mail Order 1 
Compounding 1 
Number of Suggestions per Response 
 One Suggestion 27 
2-3 Suggestions 47 
Over 4 Suggestions 27 
      *there was no distinction between retail chain and independent pharmacy 
  
Student Paper PRACTICE-BASED RESEARCH 
 
http://z.umn.edu/INNOVATIONS                      2016, Vol. 7, No. 1, Article 4                              INNOVATIONS in pharmacy   5 
 
Table 2: Raw Data for Rx-to-OTC Suggestions by Frequency 
 
Drug Rx Frequency 
Oral Contraceptives, All 40 
Albuterol 27 
Epi Pen 18 
Naloxone 14 
Nasonex 13 
Rx Toothpastes 8 
Xyzal 8 
Albuterol Spacer 6 
Antihistamines, All 6 
Clarinex 6 
Naltrexone 6 
Sumatriptan 6 
PPI, All 5 
Antabuse 4 
Hydroxyzine 4 
H2 Receptor Antagonists, All 3 
Chlorhexidine 3 
Humalog 3 
Ibuprofen, All 3 
Lovastatin 3 
Nasal Steroids 3 
Novalog 3 
Triamcinolone Cream 0.025% 3 
Clindamycin/Benzaclin Gel 2 
Dexilant 2 
Flonase 2 
Ketoconazole 2% shampoo 2 
Lantus 2 
Latisse 2 
Levemir 2 
Lidocaine 2 
Nystatin 2 
Prednisone 1mg 2 
Robitussin w/ codeine 2 
Triamcinolone Cream 0.1% 2 
Analpram 1 
Apidra 1 
Atorvastatin 1 
Combivent Inhaler 1 
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Clindamycin Cream 1% 1 
Denavir 1 
Fluoride drops 1 
Hydrocortisone Cream 2.5% 1 
Ketoconazole products 1 
Lovaza 1 
Denavir 1 
Fluoride drops 1 
Hydrocortisone Cream 2.5% 1 
Low Dose steroid creams 1 
Montelukast 1 
Mupirocin 2% 1 
Mycolog cream 1 
Naproxen, All 1 
NSAIDs, All 1 
Pataday 1 
Patanol 1 
Permethrin 5% cream/rinse 1 
Pravastatin 1 
Prednisone 1 
Prenatal Vitamins 1 
Propranolol 10mg 1 
Retin A mild strength 1 
Santyl 1 
Silver Sulfasalazine 1 
Statins 1 
Tessalon 1 
Tylenol #3 1 
Valaciclovir 1 
Voltaren Gel 1 
Weak Corticosteroids 1 
Zovirax 1 
Z-Pak 1 
TOTAL FREQUENCY RX 253 
Responses 101 
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Table 3: Raw Data for Current OTC to Rx Suggestions by Frequency 
 
Drug OTC Frequency 
Plan B 10 
Herbals, All 6 
Sudafed 5 
Dextromethorphan 4 
Primatene 4 
Bronkaid 3 
Diurex 3 
Prilosec 3 
Weight loss supplements 3 
Flonase 2 
Nexium 2 
Tylenol Combinations 2 
Acetaminophen >500mg 1 
Aspirin 1 
Aspirin >81mg 1 
Bisacodyl 1 
Black Cohosh 1 
Compression stockings 1 
Estrogen supplements 1 
Gingko Biloba 1 
Ginseng 1 
Hypodermic needles/syringes 1 
Insulin syringes 1 
Loperamide 1 
Melatonin >5mg 1 
Miralax 1 
Motrin Products, All 1 
Nasacort 1 
Nicotine Patch 1 
Pediatric APAP 1 
Prenatal vitamins 1 
Prevacid 1 
Red yeast rice 1 
Stimulants 1 
Tylenol products, All 1 
Weight lifting supplements 1 
TOTAL FREQUENCY OTC 72 
Responses 45 
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Appendix A: 
 
Survey 
 
This short survey was created by Victor Phan for his economic research at Temple University School of Pharmacy.  This research is 
about Rx-to-OTC-switch, where a prescription drug obtains OTC status.  Pharmacists, please answer the following questions. 
 
What are some prescription only medications that you think 
would be okay to sell over-the-counter? 
 
Examples of medications that were once prescription are 
Hydrocortisone cream 1%, Allegra, Plan B, Mucinex, and 
Benadryl. 
 
1 
2 
3 
4 
5 
 
What are some over-the-counter medications that you think 
should be prescription only? 
 
1 
2 
3 
4 
5 
 
Please indicate gender 
 
Male_____   Female _____ 
 
Please indicate age group 
 
20s____ 30s____40s____50s____60s____70s____ 
 
Please indicate degree 
 
BS_____  Pharm D_____ 
 
Please indicate if you are owner/manager or employee, and area 
of pharmacy (ex; retail) 
 
 
Thank you! 
Contact information: 
 
  
 
